Pulmonx Corporation

Pulmonx Corporationverified

LUNG

Price:

$7.31

Market Cap:

$286.21M

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help iden...[Read more]

Industry

Medical - Devices

IPO Date

2020-10-01

Stock Exchange

NASDAQ

Ticker

LUNG

The Current Ratio as of September 2024 (TTM) for Pulmonx Corporation (LUNG) is 8.96

According to Pulmonx Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 8.96. This represents a change of 21.13% compared to the average of 7.40 of the last 4 quarters.

Pulmonx Corporation (LUNG) Historical Current Ratio (quarterly & annually)

How has LUNG Current Ratio performed in the past?

The mean historical Current Ratio of Pulmonx Corporation over the last ten years is 8.62. The current 8.96 Current Ratio has changed 10.29% with respect to the historical average. Over the past ten years (40 quarters), LUNG's Current Ratio was at its highest in in the December 2020 quarter at 19.96. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

8.62

Median

7.81

Minimum

1.40

Maximum

19.96

Pulmonx Corporation (LUNG) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Pulmonx Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 588.12%

Maximum Annual Current Ratio = 19.96

Minimum Annual Increase = -40.61%

Minimum Annual Current Ratio = 1.40

Quarterly (TTM)
Annual
YearCurrent RatioChange
20236.49-28.95%
20229.14-22.91%
202111.85-40.61%
202019.96588.12%
20192.90107.03%

Pulmonx Corporation (LUNG) Average Current Ratio

How has LUNG Current Ratio performed in the past?

The current Current Ratio of Pulmonx Corporation (LUNG) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

9.16

5-year avg

10.07

10-year avg

8.62

Pulmonx Corporation (LUNG) Current Ratio vs. Peers

How is LUNG’s Current Ratio compared to its peers?

Pulmonx Corporation’s Current Ratio is less than IRadimed Corporation (9.87), greater than Orthofix Medical Inc. (2.48), greater than NeuroPace, Inc. (6.37), greater than Integer Holdings Corporation (3.29), greater than NuVasive, Inc. (1.25), greater than CONMED Corporation (2.34), greater than OrthoPediatrics Corp. (4.90), less than SI-BONE, Inc. (9.17), less than RxSight, Inc. (14.33), greater than AxoGen, Inc. (3.51), greater than Treace Medical Concepts, Inc. (3.86), greater than ProSomnus, Inc. Common Stock (0.30), greater than LivaNova PLC (3.45), greater than Electromed, Inc. (5.75), greater than Surmodics, Inc. (3.98), greater than Inogen, Inc. (2.70), greater than Apyx Medical Corporation (5.33),

Build a custom stock screener for Pulmonx Corporation (LUNG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pulmonx Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pulmonx Corporation (LUNG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pulmonx Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Pulmonx Corporation's Current Ratio?

How is the Current Ratio calculated for Pulmonx Corporation (LUNG)?

What is the highest Current Ratio for Pulmonx Corporation (LUNG)?

What is the 3-year average Current Ratio for Pulmonx Corporation (LUNG)?

What is the 5-year average Current Ratio for Pulmonx Corporation (LUNG)?

How does the current Current Ratio for Pulmonx Corporation (LUNG) compare to its historical average?